Literature DB >> 25590359

Epigenetic changes and functional study of HOXA11 in human gastric cancer.

Yingying Cui1, Dan Gao, Enqiang Linghu, Qimin Zhan, Runsheng Chen, Malcolm V Brock, James G Herman, Mingzhou Guo.   

Abstract

AIM: To examine epigenetic changes and the function of HOXA11 in human gastric cancer (GC). MATERIALS &
METHODS: Seven GC cell lines, five cases of normal gastric mucosa and 112 cases primary GC samples were used in this study.
RESULTS: Expression of HOXA11 and lack of promoter region methylation were found in NCI-N87, MKN45, BGC823 and HGC27 cells. Loss of expression and complete methylation were found in AGS gastric cancer cells. Reduced expression and partial methylation were found in MGC803 and SGC7901 cells. Restoration of HOXA11 expression was induced by 5-aza-2'-deoxycytidine. HOXA11 was methylated in 81.25% (91/112) of primary GCs. The presence of methylation was associated with male gender, tumor size, tumor differentiation and lymph node metastasis (all p < 0.05). Restoration of HOXA11 expression reduced cell proliferation, invasion, migration and induced apoptosis and G2/M phase arrest. HOXA11 was found to inhibit Wnt signaling by upregulating NKD1 expression.
CONCLUSION: Epigenetic silencing of HOXA11 promotes GC proliferation, migration and invasion through activation of Wnt signaling.

Entities:  

Keywords:  5-aza-2′-deoxycytidine; DNA methylation; HOXA11; NKD1; Wnt signaling pathway; epigenetics; gastric carcinoma; invasion; migration; tumor suppressor

Mesh:

Substances:

Year:  2015        PMID: 25590359     DOI: 10.2217/epi.14.92

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  19 in total

1.  An inverse interaction between HOXA11 and HOXA11-AS is associated with cisplatin resistance in lung adenocarcinoma.

Authors:  Youwei Zhang; Yuan Yuan; Yang Li; Peiying Zhang; Pingsheng Chen; Sanyuan Sun
Journal:  Epigenetics       Date:  2019-06-03       Impact factor: 4.528

2.  Exploring Prognosis-Associated Biomarkers of Estrogen-Independent Uterine Corpus Endometrial Carcinoma by Bioinformatics Analysis.

Authors:  Youchun Ye; Hongfeng Li; Jia Bian; Liangfei Wang; Yijie Wang; Hui Huang
Journal:  Int J Gen Med       Date:  2021-11-30

3.  Epigenetic inactivation of HOXA11, a novel functional tumor suppressor for renal cell carcinoma, is associated with RCC TNM classification.

Authors:  Lu Wang; Yun Cui; Jindong Sheng; Yang Yang; Guanyu Kuang; Yu Fan; Jie Jin; Qian Zhang
Journal:  Oncotarget       Date:  2017-03-28

4.  Homeobox A11 hypermethylation indicates unfavorable prognosis in breast cancer.

Authors:  Bingshu Xia; Ming Shan; Ji Wang; Zhenbin Zhong; Jingshu Geng; Xiaohui He; Tung Vu; Dekai Zhang; Da Pang
Journal:  Oncotarget       Date:  2017-02-07

5.  Evaluation of the HOXA11 level in patients with lung squamous cancer and insights into potential molecular pathways via bioinformatics analysis.

Authors:  Rui Zhang; Tong-Tong Zhang; Gao-Qiang Zhai; Xian-Yu Guo; Yuan Qin; Ting-Qing Gan; Yu Zhang; Gang Chen; Wei-Jia Mo; Zhen-Bo Feng
Journal:  World J Surg Oncol       Date:  2018-06-18       Impact factor: 2.754

6.  Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis.

Authors:  Xiao Jin; Lu Dai; Yilan Ma; Jiayan Wang; Haihao Yan; Ye Jin; Xiaojuan Zhu; Zheng Liu
Journal:  BMC Cancer       Date:  2020-09-09       Impact factor: 4.430

7.  Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma.

Authors:  Hongxia Li; Meiying Zhang; Enqiang Linghu; Fuyou Zhou; James G Herman; Liming Hu; Mingzhou Guo
Journal:  Clin Epigenetics       Date:  2018-11-06       Impact factor: 6.551

8.  Whole genome and transcriptome sequencing of matched primary and peritoneal metastatic gastric carcinoma.

Authors:  J Zhang; J Y Huang; Y N Chen; F Yuan; H Zhang; F H Yan; M J Wang; G Wang; M Su; G Lu; Y Huang; H Dai; J Ji; J Zhang; J N Zhang; Y N Jiang; S J Chen; Z G Zhu; Y Y Yu
Journal:  Sci Rep       Date:  2015-09-02       Impact factor: 4.379

9.  Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.

Authors:  Young-Bem Se; Seung Hyun Kim; Ji Young Kim; Ja Eun Kim; Yun-Sik Dho; Jin Wook Kim; Yong Hwy Kim; Hyun Goo Woo; Se-Hyuk Kim; Shin-Hyuk Kang; Hak Jae Kim; Tae Min Kim; Soon-Tae Lee; Seung Hong Choi; Sung-Hye Park; Il Han Kim; Dong Gyu Kim; Chul-Kee Park
Journal:  Cancer Res Treat       Date:  2016-07-19       Impact factor: 4.679

10.  Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma.

Authors:  Yulin Guo; Yaojun Peng; Dan Gao; Meiying Zhang; Weili Yang; Enqiang Linghu; James G Herman; François Fuks; Guanglong Dong; Mingzhou Guo
Journal:  Clin Epigenetics       Date:  2017-10-23       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.